How to allocate intensive care resources during the COVID-19 pandemic: medical triage or a priori selection?

The relationship between vaccine acceptance and COVID-19 mortality in Europe: A Cross-Country analysis of public opinion and Epidemiological data

“…In spite of some encouraging results regarding drug repurposing and new drugs becoming available for COVID-19 treatment [19] , widespread vaccination still remains the primary strategy employed to put an end to the pandemic. By reducing hospitalization rates and intensive care occupancy, healthcare costs would drop significantly, allowing for better resource allocation [20] . Therefore, it is crucial to continue encouraging widespread immunization through vaccination in order to more quickly achieve improvement in the epidemiological situation of this and potential future pandemics across Europe.…”

Could fluvoxamine keep COVID-19 patients out of hospitals and intensive care units?

“…A widespread use of such drugs could reduce hospitalization rates and mortality, allowing a fully outpatient management of COVID-19. Consequently, a reduction in intensive care units occupancy by COVID-19 patients would also reduce the health care costs and allow a better health care resource allocation, which has been an ongoing problem since the start of the pandemic ( 6 ). The development of new medicines requires considerable amounts of time and financial resources.…”

Optimizing the diagnostic capacity for COVID-19 PCR testing for low resource and high demand settings: The development of information-dependent pooling protocol

“…As such, it is of high interest in resource-restraint situations, regardless of the reagents, equipment or time. The emergence of COVID-19 has introduced such a situation globally, with huge increase in the diagnostic demand that requires optimization of laboratory workflow and entire health care [ 1 , 2 ].…”